Laura A. Lane
Corporate Officer/Principal chez ELI LILLY AND COMPANY
Profil
Laura A.
Lane was the founder of Virion Biotherapeutics Ltd.
which was founded in 2015, where she held the title of Chief Operating Officer & Director from 2015 to 2018.
Currently, she is a Vice President at Eli Lilly & Co. since 2022.
Previously, she worked as a Principal at Advent Venture Partners LLP from 2019 to 2022.
Ms. Lane received her undergraduate and doctorate degrees from the University of Cambridge.
Postes actifs de Laura A. Lane
| Sociétés | Poste | Début |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2022 |
Anciens postes connus de Laura A. Lane
| Sociétés | Poste | Fin |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Analyste en capital-investissement | 01/10/2021 |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Fondateur | 30/06/2018 |
Formation de Laura A. Lane
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
